BALYASNY ASSET MANAGEMENT L.P.

Holdings History for Lexeo Therapeutics, Inc. - Common Stock ($0.0001 par value) (the "Shares") (LXEO)

Symbol: LXEO on Nasdaq
Investment type: Equity / Common Stock ($0.0001 par value) (the "Shares")
Latest Disclosed Shares Owned: 7,221,555 shares
Security Ownership %: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Balyasny Asset Management L.P. ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO)

17 Feb 2026 - Balyasny Asset Management L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,221,555 shares of Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO). This represents 9.9% ownership of the company. In their previous filing dated 14 Nov 2025, BALYASNY ASSET MANAGEMENT L.P. had reported owning 5,394,721 shares, indicating an increase of +34%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Balyasny Asset Management L.P.	9.9%	-1%	$53,656,154	7,221,555	+1,826,834	+34%	$7.43	13G/A	31 Dec 2025	17 Feb 2026, 06:39
Balyasny Asset Management L.P.	10%	0%	$35,820,947	5,394,721	-2,950,930	-35%	$6.64	13G/A	30 Sep 2025	14 Nov 2025, 06:04
Balyasny Asset Management L.P.	10%		$38,389,995	8,345,651			$4.60	13G	30 Jun 2025	14 Aug 2025, 06:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	-0.04%	$16,235,808	1,635,026	-2,278,762	-58%	$9.93	Q4 2025
30 Sep 2025	0.05%	-0%	$25,987,552	3,913,788	-95,349	-2.4%	$6.64	Q3 2025
30 Jun 2025	0.04%	+0.04%	$16,116,731	4,009,137	+4,009,137	NEW	$4.02	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.